Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 324

1.

A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees.

Dalsgareth OJ, Hansen NC, Søes-Petersen U, Evald T, Høegholm A, Barber J, Vestbo J.

Nicotine Tob Res. 2004 Feb;6(1):55-61.

PMID:
14982688
2.

Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial.

Hays JT, Hurt RD, Rigotti NA, Niaura R, Gonzales D, Durcan MJ, Sachs DP, Wolter TD, Buist AS, Johnston JA, White JD.

Ann Intern Med. 2001 Sep 18;135(6):423-33.

PMID:
11560455
3.

Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study.

Tonstad S, Farsang C, Klaene G, Lewis K, Manolis A, Perruchoud AP, Silagy C, van Spiegel PI, Astbury C, Hider A, Sweet R.

Eur Heart J. 2003 May;24(10):946-55.

PMID:
12714026
4.

A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation.

Tønnesen P, Tonstad S, Hjalmarson A, Lebargy F, Van Spiegel PI, Hider A, Sweet R, Townsend J.

J Intern Med. 2003 Aug;254(2):184-92.

5.
6.

Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation.

Johnston JA, Fiedler-Kelly J, Glover ED, Sachs DP, Grasela TH, DeVeaugh-Geiss J.

Nicotine Tob Res. 2001 May;3(2):131-40.

PMID:
11403727
7.

Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: a randomized placebo-controlled study.

Gonzales DH, Nides MA, Ferry LH, Kustra RP, Jamerson BD, Segall N, Herrero LA, Krishen A, Sweeney A, Buaron K, Metz A.

Clin Pharmacol Ther. 2001 Jun;69(6):438-44.

PMID:
11406741
8.

Sustained-release bupropion for hospital-based smoking cessation: a randomized trial.

Simon JA, Duncan C, Huggins J, Solkowitz S, Carmody TP.

Nicotine Tob Res. 2009 Jun;11(6):663-9. doi: 10.1093/ntr/ntp047. Epub 2009 Apr 24.

PMID:
19395688
9.
10.

Bupropion SR vs placebo for smoking cessation in health care professionals.

Zellweger JP, Boelcskei PL, Carrozzi L, Sepper R, Sweet R, Hider AZ.

Am J Health Behav. 2005 May-Jun;29(3):240-9.

PMID:
15899687
11.

A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia.

Evins AE, Cather C, Deckersbach T, Freudenreich O, Culhane MA, Olm-Shipman CM, Henderson DC, Schoenfeld DA, Goff DC, Rigotti NA.

J Clin Psychopharmacol. 2005 Jun;25(3):218-25.

PMID:
15876899
12.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
13.

Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo.

Jamerson BD, Nides M, Jorenby DE, Donahue R, Garrett P, Johnston JA, Fiore MC, Rennard SI, Leischow SJ.

Clin Ther. 2001 May;23(5):744-52.

PMID:
11394732
14.

Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.

Aubin HJ, Lebargy F, Berlin I, Bidaut-Mazel C, Chemali-Hudry J, Lagrue G.

Addiction. 2004 Sep;99(9):1206-18.

PMID:
15317642
15.

Two-year follow-up of a smoking cessation trial in patients with schizophrenia: increased rates of smoking cessation and reduction.

Evins AE, Cather C, Rigotti NA, Freudenreich O, Henderson DC, Olm-Shipman CM, Goff DC.

J Clin Psychiatry. 2004 Mar;65(3):307-11; quiz 452-3.

PMID:
15096068
16.

A double-blind, placebo-controlled, randomized trial of bupropion for smoking cessation in primary care.

Fossati R, Apolone G, Negri E, Compagnoni A, La Vecchia C, Mangano S, Clivio L, Garattini S; General Practice Tobacco Cessation Investigators Group.

Arch Intern Med. 2007 Sep 10;167(16):1791-7.

PMID:
17846399
17.

A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia.

Evins AE, Mays VK, Rigotti NA, Tisdale T, Cather C, Goff DC.

Nicotine Tob Res. 2001 Nov;3(4):397-403.

PMID:
11694208
18.

Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt.

West R, Baker CL, Cappelleri JC, Bushmakin AG.

Psychopharmacology (Berl). 2008 Apr;197(3):371-7. Epub 2007 Dec 15.

PMID:
18084743
19.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
20.

Supplemental Content

Support Center